Monocrotaline metabolism and distribution in Fisher 344 and Sprague- Dawley rats

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 117, Issue 1, 1997, Pages 115-123

  Reid, M J ^a   Lame M W ^a   Morin, O ^a   Wilson, D W ^a   Segall, H J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fisher 344; liver perfusion; metabolism; monocrotalic acid; monocrotaline; pyrrolizidine alkaloid; Sprague Dawley

Indexed keywords

MONOCROTALINE;

ANIMAL EXPERIMENT; ARTICLE; DISEASE PREDISPOSITION; DRUG DEGRADATION; DRUG EXCRETION; DRUG OXIDATION; LIVER MICROSOME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; STRAIN DIFFERENCE; TOXICITY TESTING;

ANIMALIA; MARTES PENNANTI;

EID: 0030909104     PISSN: 03050491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-0491(96)00323-9     Document Type: Article

References (41)

1. Adams, R.; Rogers, E.M. The structure of monocrotaline the alkaloid in Crotalaria spectabilis and C. retusa. J. Am. Chem. Soc. 1:2815-2819;1939.
2. Brockmoller, J.; Roots, I. Assessment of liver metabolic function. Clinical implications. Clin. Pharmacokin. 27:216-248; 1994.
3. Bull, L.B.; Culvenor, C.C.J.; Dick, A.J. Pyrrolizidine alkaloids: Their chemistry, pathogenicity and other biological properties. Amsterdam, The Netherlands: North-Holland; 1968.
4. Carrillo, L.; Aviado, D.M. Monocrotaline-induced pulmonary hypertension and p-chlorophenylalanme (PCPA). Lab. Invest. 20:243-248;1969.
5. Chesney, C.F.; Allen, J.R. Monocrotaline induced pulmonary vascular lesions in non-human primates. Cardiovasc. Res. 7: 508-518;1973.
6. Chesney, C.F.; Allen, J.R. Resistance of guinea pig pyrrolizidine alkaloid intoxication. Tox. Appl. Pharm. 26:385-392; 1973.
7. Chu, P.S.; Lamé, M.W.; Segall, H.J. In vivo metabolism of retrorsine and retrorsine-N-oxide. Arch. Tox. 67:39-43; 1993.
8. Culvenor, C.C.J.; Smith, L.W. The alkaloids of Crotalaria retusa L. Aust. J. Chem. 10:464-473;1957.
9. Dalvi, R.R. Dose-related inhibition of the drug-metabolizing enzymes of rat liver by the pyrrolizidine alkaloid, monocrota-line. J. Pharm. Pharmacol. 39:386-388;1987.
10. Dueker, S.R.; Lamé, M.W.; Morin, D.; Wilson, D.W.; Segall, H.J. Guinea pig and rat hepatic microsomal metabolism of monocrotaline. Drug Metab. Dispos. 20:275-280;1992.
11. Eastman, D.F.; Dimenna, G.P.; Segall, H.J. Covalent binding of two pyrrolizidine alkaloids, senecionine and seneciphylline, to hepatic macromolecules and their distribution, excretion and transfer into milk of lactating mice. Drug Metab. Dispos. 10:236-240;1982.
12. 14C] Monocrotaline kinetics and metabolism in the rat. Drug Metab. Dispos. 19:135-139;1991.
13. Halpert, J.R.; Guengerich, F.P.; Bend, J.R.; Correia, M.A. Selective inhibitors of cytochromes P450. Tox. Appl. Pharm. 125:163-175;1994.
14. Hartmann, T.; Witte, L. Chemistry, biology and chemoecology of the pyrrolizidine alkaloids. In: Pelletier, S.W. (ed). Alkaloids: Chemical and Biological Perspectives, Vol. 9. Tarrytown, NY: Pergamon Press; 1995:155-233.
15. Hilliker, K.S.; Bell, T.G.; Roth, R.A. Pneumotoxicity and thrombocytopenia after a single injection of monocrotaline. Am. J. Physiol. 242:H573-579;1982.
16. Hoorn, C.M.; Wagner, J.G.; Roth, R.A. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium. Tox. Appl. Pharm. 120:281-287;1993.
17. Hoskins, M.W.; Crout, D.H.G. Pyrrolizidine alkaloid analogues: Preparation of semisynthetic esters of retronecine. J. Chem. Soc. Perkin 1:538-544;1977.
18. Huxtable, R.J.; Stillman, A.; Consroe, P.; Kohnen, P.; Smith, S. Characterization of alkaloids involved in human pyrrolizidine (senecio) poisonings in Arizona. Gastroent. 73: 349-352;1977.
19. Lafronconi, W.M.; Huxtable, R.J. Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Bioch. Biophys. Res. Commun. 33:2479-2484; 1984.
20. Lamé, M.W.; Morin, D.; Jones, A.D.; Segall, H.J.; Wilson, D.W. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Tox. Lett. 51:321-329;1990.
21. 14C] monocrotaline by isolated perfused liver. Drug Metab. Dispos. 19:516-524;1991.
22. 14C] monocrotaline in the rat. Drug Metab. Dispos. 23:422-429;1995.
23. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275;1951.
24. Mattocks, A.R. Toxicity of pyrrolizidine alkaloids. Nature 217:723-728;1968.
25. Mattocks, A.R. Dihydropyrrolizine derivatives from unsaturated pyrrolizidine alkaloids. J. Chem. Soc. C:1115-1162; 1969.
26. Mattocks, A.R. Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids. Chem. Biol. Interact. 5:227-242;1972.
27. Mattocks, A.R. Chemistry and toxicology of pyrrolizidine alkaloids. New York: Academic Press; 1986.
28. Mattocks, A.R.; White, I.N.H. The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. Chem. Biol. Interact. 3: 383-396;1971.
29. McClean, E.K. The toxic actions of pyrrolizidine (senecio) alkaloids. Pharm. Rev. 22:429-483;1970.
30. Miller, W.C.; Rice, D.L.; Kreusel, R.G.; Bedrossian, W.M. Monocrotaline model of noncardiogenic pulmonary edema in dogs. J. Appl. Physiol. 45:962-965;1978.
31. Miranda, C.L.; Chung, W.; Reed, R.E.; Zhao, X.; Henderson, M.C.; Wang, J.L.; Williams, D.E.; Buhler, D.R. Flavin-containing monooxygenase: A major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. Biochem. Biophys. Res. Commun. 178:546-552;1991.
32. Pan, L.C.; Lamé, M.W.; Morin, D.; Wilson, D.W.; Segall, H.J. Red blood cells augment transport of reactive metabolites of monocrotaline from liver to lung in isolated and tandem liver and lung perfusions. Tox. Appl. Pharm. 110:336-346;1991.
33. Pan, L.C.; Wilson, D.W.; Lamé, M.W.; Jones, A.D.; Segall, H.J. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine. Tox. Appl. Pharm, 118:87-97; 1993.
34. Pan, L.C.; Wilson, D.W.; Segall, H.J. Strain differences in the response of Fisher 344 and Sprague-Dawley rats to MCT-induced pulmonary vascular disease. Toxicol. 79:21-35;1993.
35. Segall, H.J.; Brown, C.H.; Paige, D.F. The biosynthesis of three macrocyclic pyrrolizidine alkaloids, retrorsine, seneciphylline and senecionine using Senecio vulgaris. J. Labeled Compounds 20:671-689;1983.
36. Shulman, H.M.; Luk, K.; Deeg, H.J.; Shulman, W.B.; Storb, R. Induction of hepatic veno-occlusive disease in dogs. J. Am. Pathol. 126:114-125;1987.
37. Sugita, T.; Hyers, T.M.; Dauber, I.M.; Wagner, W.W.; McMurtry, I.F.; Reeves, J.T. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J. Appl. Physiol. 54:371-376;1983.
38. Sun, J.D.; Dent, J.G. A new method for measuring covalent binding of chemicals to cellular macromolecules. Chem. Biol. Inter. 32:41-61;1980.
39. Williams, D.E.; Reed, R.L.; Kedzierski, B.; Dannan, G.A.; Guengerich, P.; Buhler, D.R. Bioactivation and detoxication of the phyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver. Drug Metab. Dispos. 17:387-392; 1989.
40. Wilson, D.W.; Segall, H.J.; Pan, L.C.; Dunston, S.K. Progressive inflammatory and structural changes in the pulmonary vasculature of MCT-induced rats. Microvasc. Res. 38:57-80; 1989.
41. Wilson, D.W.; Segall, H.J.; Pan, L.C.; Lamé, M.W.; Estep, J.E.; Morin, D. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Tox. 22:307-325;1992.